TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration

Regulatory Peptides

Volumn 167, Issue 2-3, 2011, Pages 250-258

  Heng, Yujing J ^a   Saunders, Cassandra I M ^a   Kunde, Dale A ^a   Geraghty, Dominic P ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Capsaicin; Immunohistochemistry; MRNA; QPCR; Resiniferatoxin; Tachykinins

Indexed keywords

CAPSAICIN; MESSENGER RNA; NEUROKININ 1 RECEPTOR; RESINIFERATOXIN; SUBSTANCE P; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; IMMUNOREACTIVITY; LUMBOSACRAL SPINE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UROTHELIUM;

ANIMALS; CAPSAICIN; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; LUMBAR VERTEBRAE; MALE; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; RNA, MESSENGER; SACRUM; SPINAL CORD; SUBSTANCE P; TRPV CATION CHANNELS; URINARY BLADDER;

RATTUS;

EID: 79953200103     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.02.004     Document Type: Article

References (44)

1. Dhaka A., Uzzell V., Dubin A., Mathur J., Petrus M., Bandell M., Patapoutian A. TRPV1 is activated by both acidic and basic pH. J Neurosci 2009, 29:153-158.
2. Gunthorpe M., Benham C., Randall A., Davis J. The diversity in the vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol Sci 2002, 23:183-191.
3. Cortright D., Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 2004, 271:1814-1819.
4. Geppetti P., Trevisani M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br J Pharmacol 2004, 141:1313-1320.
5. Sanchez M., Sanchez A., Collado B., Malagarie-Cazenave S., Olea N., Carmena M., Prieto J., Diaz-Laviada I. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur J Pharmacol 2005, 515:20-27.
6. Szallasi A. Vanillid (capsaicin) receptors in health and disease. Am J Clin Pathol 2002, 118:110-121.
7. Otsuka M., Yanagisawa M. Does substance P act as a pain transmitter?. Trends Pharmacol Sci 1987, 8:506-510.
8. Jessell T., Iversen L., Cuello A. Capsaicin induced depletion of substance P from primary sensory neurons. Brain Res 1978, 152:183-188.
9. Szallasi A., Blumberg P. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999, 51:159-212.
10. Szolcsanyi J. Actions of capsaicin on sensory receptors. Capsaicin in the study of pain 1993, 1-27. Academic Press, London. J. Wood (Ed.).
11. Avelino A., Cruz C., Nagy I., Cruz F. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 2002, 109:787-798.
12. Birder L., Kanai A., de Groat W., Kiss S., Nealen M., Burke N., Dineley K., Watkins S., Reynolds I., Caterina M. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Nat Acad Sci USA 2001, 98:13396-13401.
13. Imamura T., Ishizuka O., Zhong C., Ogawa T., Nakayama T., Kurizaki Y., Tanabe T., Nishizawa O., Andersson K.E. An extract (THC-002) of Ba-Wei-Die-Huang-Wan inhibits expression of tachykinins, and P2X3 and TRPV1 receptors, and inhibits ATP-induced detrusor overactivity in spontaneously hypertensive rats. Neurourol Urodyn 2009, 28:529-534.
14. Yamada T., Ugawa S., Ueda T., Ishida Y., Kajita K., Shimada S. Differential localizations of the transient receptor potential channels TRPV4 and TRPV1 in the mouse urinary bladder. J Histochem Cytochem 2009, 57:277-287.
15. National Health and Medical Research Council of Australia Australian code of practice for the care and use of animals for scientific purposes 2004.
16. de Sousa B., Horrocks L. Development of rat spinal cord: I. Weight and length with a method for rapid removal. Neuroscience 1979, 2:115-121.
17. The rat brain in stereotaxic coordinates 1986, Academic Press Inc, United States of America. G. Paxinos, C. Watson (Eds.).
18. Chen S.R., Pan H.L. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. J Neurophysiol 2006, 95:3086-3096.
19. Jeffry J.A., Yu S.Q., Sikand P., Parihar A., Evans M.S., Premkumar L.S. Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia. PLoS ONE 2009, 4:e7021.
20. Cruz C.D., Charrua A., Vieira E., Valente J., Avelino A., Cruz F. Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals. Exp Neurol 2008, 214:301-308.
21. Mantyh P., Gates T., Mantyh C., Maggio J. Autoradiographic localisation and characterisation of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci 1989, 9:258-279.
22. Pan H., Kahan G., Alloway K., Chen S. Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J Neurosci 2003, 23:2911-2919.
23. Szallasi A., Nilsson S., Farkas-Szallasi T., Blumberg P., Hokfelt T., Lundberg J. Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res 1995, 703:175-183.
24. Zhou H.Y., Chen S.R., Chen H., Pan H.L. The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn. J Neurochem 2009, 108:305-318.
25. Abbadie C., Brown J., Mantyh P., Basbaum A. Spinal cord substance P receptor-immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience 1996, 70:201-209.
26. Gamse R., Lackner D., Gamse G., Leeman S. Effect of capsaicin pretreatment on capsaicin evoked release of immunoreactive somatostatin and substance P from primary sensory neurons. Naunyn-Schmiedeberg's Arch Pharmacol 1981, 316:38-41.
27. Hayes A., Tyers M. Effects of capsaicin on nociceptive heat, pressure and chemical thresholds and on substance P levels in the rat. Brain Res 1980, 189:561-564.
28. Velazquez R., McCarson K., Cai Y., Kovacs J., Shi Q., Evensji M., Larson A. Upregulation of neurokinin-1 receptor expression in rat spinal cord by an N-terminal metabolite of substance P. Eur J Neurosci 2002, 16:229-241.
29. Garland A., Grady E., Payan D., Vigna S., Bunnett N. Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells. Biochem J 1994, 303:177-186.
30. Mantyh P., Allen C., Ghilardi J., Rogers S., Mantyh C., Liu H., Basbaum A., Vigna S., Maggio J. Rapid endocytosis of a G protein-coupled receptor: substance P-evoked internalization of its receptor in the rat striatum in vivo. Proc Natl Acad Sci USA 1995, 92:2622-2626.
31. Mantyh P., DeMaster E., Malhotra A., Ghilardi J., Rogers S., Mantyh C., Liu H., Basbaum A., Vigna S., Maggio J., Simone D. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 1995, 268:1629-1632.
32. Bowden J., Garland A., Baluk P., Lefevre P., Grady E., Vigna S., Bunnett N., McDonald D. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci USA 1994, 91:8964-8968.
33. Szallasi A., Farkas-Szallasi T., Tucker J., Lundberg J., Hokfelt T., Krause J. Effects of systemic resiniferatoxin treatment on substance P mRNA in rat dorsal root ganglia and substance P receptor mRNA in the spinal dorsal horn. Brain Res 1999, 815:177-184.
34. Blumberg P., Szallasi A., Acs G. Resiniferatoxin - an ultrapotent capsaicin analogue. Capsaicin in the study of pain 1993, 45-62. Academic Press, London. J. Wood (Ed.).
35. Cruz F. Vanilloid receptor and detrusor instability. Urology 2002, 59:51-60.
36. Chancellor M., de Groat W. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol 1999, 162.
37. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J., Blanchard J., Laduron P. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Nat Acad Sci 1991, 88:10208-10212.
38. Everaerts W., Sepulveda M.R., Gevaert T., Roskams T., Nilius B., De Ridder D. Where is TRPV1 expressed in the bladder, do we see the real channel?. Naunyn-Schmiedeberg's Arch Pharmacol 2009, 379:421-425.
39. Liu L., Mansfield K.J., Kristiana I., Vaux K.J., Millard R.J., Burcher E. The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder. Neurourol Urodyn 2007, 26:433-438. discussion 9; discussion 51-3.
40. Banasiak D., Burcher E. Effect of capsaicin on distribution of binding sites for tachykinins and calcitonin gene-related peptide in rat urinary bladder: a quantitative autoradiographic study. Peptides 1994, 15:333-339.
41. Burcher E. The study of tachykinin receptors. Clin Exp Pharmacol Physiol 1989, 16:539-543.
42. Quartara L., Maggi C. The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles. Neuropeptides 1998, 32:1-49.
43. Morrison J., Nimmo A., Whitaker E. The effect of neonatal capsaicin treatment on the distribution of neurokinin binding sites in rat bladder. J Physiol 1989, 423:79.
44. Geraghty D., Burcher E. Effect of chronic capsaicin treatment on tachykinin NK1 binding sites in the rat. Peptides 1992, 13:409-411.